Skip to main content

Table 2 Association of overall and progression-free survival with DNAm age

From: Epigenetic age acceleration of cervical squamous cell carcinoma converged to human papillomavirus 16/18 expression, immunoactivation, and favourable prognosis

DNAm age

Totala

Overall survival

Progression-free survival

HR (95% CI)b

P

HR (95% CI)b

P

Continuous (per 10 years)

244

0.88 (0.78–0.99)

0.03

0.90 (0.80–1.01)

0.09

Categorical (quartile)c

 First

60

1.00 (ref)

–

1.00 (ref)

–

 Second

60

0.85 (0.44–1.62)

0.61

1.07 (0.54–2.09)

0.85

 Third

61

0.60 (0.28–1.26)

0.17

0.84 (0.39–1.81)

0.65

 Fourth

63

0.32 (0.14–0.74)

0.008

0.35 (0.14–0.88)

0.03

Categorical (binary)

 Decelerated

145

1.00 (ref)

–

1.00 (ref)

–

 Accelerated

99

0.59 (0.35–1.00)

0.05

0.53 (0.30–0.93)

0.03